Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

96.63 +0.95 (+0.99%)
Official Closing Price Updated: 7:00 PM EST, Jan 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,522,836
Open 96.11
Bid (Size) 96.45 (2)
Ask (Size) 96.98 (4)
Prev. Close 95.68
Today's Range 95.22 - 97.16
52wk Range 94.48 - 134.63
Shares Outstanding 2,531,374,696
Dividend Yield 3.19%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
RJK Jr.'s Involvement In Merck Lawsuit Faces Scrutiny Ahead Of Senate Hearing
Robert F. Kennedy Jr., HHS secretary nominee, faces criticism for financial ties to vaccine lawsuits, raising ethical concerns over regulatory impartiality. 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
NYSE:MRK is probably undervalued for the fundamentals it is displaying.
MERCK & CO. INC. (NYSE:MRK) is an undervalued gem with solid fundamentals. 
Via Chartmill

Performance

YTD
-2.56%
-2.56%
1 Month
-2.84%
-2.84%
3 Month
-8.74%
-8.74%
6 Month
-23.22%
-23.22%
1 Year
-18.72%
-18.72%

More News

Read More
3 Unstoppable Stocks to Buy That Wall Street Thinks Will Soar More Than 35%
Via The Motley Fool
Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside
Via Benzinga
Moderna Surges After Larry Ellison Calls Out The Potential Of AI In Cancer Vaccines
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
Price Over Earnings Overview: Merck & Co
Via Benzinga
Unpacking the Latest Options Trading Trends in Merck & Co
Via Benzinga
Why Summit Therapeutics Stock Is Jumping Today
Via The Motley Fool
Can the 8 Worst-Performing Dow Jones Stocks in 2024 Beat the S&P 500 in 2025?
Via The Motley Fool
Topics Stocks
Exposures US Equities
Earnings Season Scorecard And Fresh Analyst Reports For Chevron, Merck & Others
Via Talk Markets
Topics Stocks / Equities
Healthcare And Biotech Stocks Lag The Market Again
Via Talk Markets
Topics Stocks / Equities
AI Drug Discovery Startups: Analysis Of Exscientia’s Acquisition By Recursion
Via Talk Markets
Topics Artificial Intelligence Stocks / Equities
Exposures Artificial Intelligence
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
Via Benzinga
Topics Economy
Exposures Interest Rates
Merck to Hold Fourth-Quarter and Full-Year 2024 Sales and Earnings Conference Call Feb. 4
From Merck & Co., Inc.
Via Business Wire
3 Magnificent S&P 500 Dividend Stocks Down 25%, 60%, and 26% to Buy and Hold Forever
Via The Motley Fool
Topics Stocks
Exposures US Equities
What Lies Ahead In 2025? Slower Growth, More Volatility
Via Talk Markets
Topics Economy Stocks / Equities
Exposures Economy
Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?
Via Investor's Business Daily
Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
Via Benzinga
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
Via Investor's Business Daily
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political
Moderna Shares Spike on H5N1 News—What’s Next for Investors?
Via MarketBeat
Salesforce To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
This Adobe Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Via Benzinga
Merck’s GARDASIL® Receives Expanded Approval for Males in China
From Merck & Co., Inc.
Via Business Wire
Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside
Via Benzinga
Merck Buys WuXi Vaccines' Irish Manufacturing Facility For Over $500 Million
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.